• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Diagnosis: Treatments: Leading Products - Disease and Therapy Review: Alzheimers Disease

Posted on: Tuesday, 28 August 2007, 12:16 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c66872) has announced the addition of Disease and Therapy Review: Alzheimers Disease to their offering.

The Alzheimers Dementia Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments.

Dosing information and treatment costs are provided for:

- Aricept

- Namenda

- Razadyne

- Exelon

General sales information is also included for these four products.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.

Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.

Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. This information is supplemented by reviews of analyst reports, company reports, and medical websites.

Report breakdown:

- OVERVIEW

- INCIDENCE AND PREVALENCE

- DIAGNOSIS

- TREATMENT

- DOSING

- TREATMENT COSTS

- MARKET SIZE

- COMMENTS

- REFERENCES/RESOURCES

For more information visit http://www.researchandmarkets.com/reports/c66872

Source: Business Wire

More News in this Category